Dr. Aaron Berger Discusses A New Wave Of Bladder Cancer Therapies

Dr. Aaron Berger, CMO/VP

At the American Urological Association (AUA) 2025 Annual Meeting, an expert panel convened to discuss the evolving treatment and diagnostic landscape of non-muscle invasive bladder cancer (NMIBC). Moderated by Sia Daneshmand, MD, University of Southern California, the roundtable consisted of Mark D. Tyson, MD, Mayo Clinic; Aaron Berger, MD, Associated Urological Specialists; and Vignesh T.…

Read More